- Home
- IH vs VTVT Comparison
IH vs VTVT Comparison
Compare IH & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IH | VTVT |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.0M | 127.0M |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | IH | VTVT |
|---|---|---|
| Price | $1.84 | $33.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $51.33 |
| AVG Volume (30 Days) | 14.2K | ★ 21.5K |
| Earning Date | 12-29-2025 | 11-06-2025 |
| Dividend Yield | ★ 4.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $119,261,855.00 | $17,000.00 |
| Revenue This Year | $39.02 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.57 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.60 | $13.46 |
| 52 Week High | $3.60 | $44.00 |
Technical Indicators
Market Signals| Indicator | IH | VTVT |
|---|---|---|
| Relative Strength Index (RSI) | 29.09 | 46.49 |
| Support Level | $1.80 | $31.80 |
| Resistance Level | $1.95 | $41.95 |
| Average True Range (ATR) | 0.08 | 3.40 |
| MACD | 0.00 | -1.05 |
| Stochastic Oscillator | 10.02 | 19.44 |
Price Performance
Historical ComparisonAbout IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin, currently in a Phase 3 trial, a potential novel first-in-class oral liver-selective glucokinase activator being investigated for the treatment of type 1 diabetes. The group and its development partners are investigating multiple molecules across different indications for chronic diseases. Its product pipeline are HPP737, Azeliragon, TTP-RA, TTP273, HPP971 / HPP3033, and HPP593.